JP2024512121A5 - - Google Patents
Info
- Publication number
- JP2024512121A5 JP2024512121A5 JP2023560146A JP2023560146A JP2024512121A5 JP 2024512121 A5 JP2024512121 A5 JP 2024512121A5 JP 2023560146 A JP2023560146 A JP 2023560146A JP 2023560146 A JP2023560146 A JP 2023560146A JP 2024512121 A5 JP2024512121 A5 JP 2024512121A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- approximately
- composition
- cps
- viscosity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202121015680 | 2021-04-01 | ||
| IN202121015680 | 2021-04-01 | ||
| PCT/IB2021/055221 WO2022208146A1 (en) | 2021-04-01 | 2021-06-14 | Nasal compositions comprising alcaftadine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512121A JP2024512121A (ja) | 2024-03-18 |
| JP2024512121A5 true JP2024512121A5 (OSRAM) | 2024-06-18 |
Family
ID=76523258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560146A Pending JP2024512121A (ja) | 2021-04-01 | 2021-06-14 | アルカフタジンを含む鼻用組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US20240173331A1 (OSRAM) |
| EP (1) | EP4312973A1 (OSRAM) |
| JP (1) | JP2024512121A (OSRAM) |
| KR (1) | KR20230163413A (OSRAM) |
| CN (1) | CN117120029A (OSRAM) |
| AU (1) | AU2021437358A1 (OSRAM) |
| BR (1) | BR112023019795A2 (OSRAM) |
| CA (1) | CA3213156A1 (OSRAM) |
| CL (1) | CL2023002871A1 (OSRAM) |
| MX (1) | MX2023011546A (OSRAM) |
| WO (1) | WO2022208146A1 (OSRAM) |
| ZA (1) | ZA202308388B (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240173331A1 (en) * | 2021-04-01 | 2024-05-30 | Alkem Laboratories Limited | Nasal compositions comprising alcaftadine |
| CN114504037B (zh) * | 2022-01-14 | 2024-12-03 | 云南中茶茶业有限公司 | 一种茶叶发酵瓶用出瓶机 |
| US11992493B1 (en) * | 2022-10-25 | 2024-05-28 | Liangdan Sun | Use of compound or pharmaceutical derivative thereof in inhibiting CaMK2G protein activity |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2053678T3 (es) | 1987-11-13 | 1994-08-01 | Asta Medica Ag | Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular. |
| IL101850A (en) | 1991-06-13 | 1996-01-31 | Janssen Pharmaceutica Nv | 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them |
| US7666876B2 (en) * | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
| BRPI0615032A2 (pt) | 2005-09-01 | 2011-04-26 | Biolipox Ab | composição farmacêutica, processo para a preparação da mesma, e, uso de uma composição |
| JP5292277B2 (ja) | 2006-03-31 | 2013-09-18 | ビスタコン・フアーマシユーチカルズ・エルエルシー | 眼アレルギーの処置 |
| JP2014518278A (ja) * | 2011-06-29 | 2014-07-28 | アラーガン インコーポレイテッド | 蕁麻疹の治療に用いるアルカフタジン |
| CN102283849A (zh) | 2011-06-29 | 2011-12-21 | 北京阜康仁生物制药科技有限公司 | 一种含有阿卡他定的药物组合物 |
| JP7191022B2 (ja) | 2017-07-28 | 2022-12-16 | 参天製薬株式会社 | アルカフタジン又はその塩を含有する水性医薬組成物 |
| JP7791119B2 (ja) * | 2020-06-15 | 2025-12-23 | アルケム・ラボラトリーズ・リミテッド | アルカフタジンとコルチコステロイドの組み合わせ |
| US20240173331A1 (en) * | 2021-04-01 | 2024-05-30 | Alkem Laboratories Limited | Nasal compositions comprising alcaftadine |
-
2021
- 2021-06-14 US US18/549,916 patent/US20240173331A1/en active Pending
- 2021-06-14 CA CA3213156A patent/CA3213156A1/en active Pending
- 2021-06-14 CN CN202180096503.1A patent/CN117120029A/zh active Pending
- 2021-06-14 KR KR1020237033154A patent/KR20230163413A/ko active Pending
- 2021-06-14 EP EP21733563.7A patent/EP4312973A1/en active Pending
- 2021-06-14 JP JP2023560146A patent/JP2024512121A/ja active Pending
- 2021-06-14 WO PCT/IB2021/055221 patent/WO2022208146A1/en not_active Ceased
- 2021-06-14 BR BR112023019795A patent/BR112023019795A2/pt unknown
- 2021-06-14 MX MX2023011546A patent/MX2023011546A/es unknown
- 2021-06-14 AU AU2021437358A patent/AU2021437358A1/en active Pending
-
2023
- 2023-08-30 ZA ZA2023/08388A patent/ZA202308388B/en unknown
- 2023-09-26 CL CL2023002871A patent/CL2023002871A1/es unknown
-
2024
- 2024-11-11 US US18/943,124 patent/US20250064825A1/en not_active Abandoned
- 2024-11-11 US US18/943,210 patent/US12274702B2/en active Active
- 2024-11-11 US US18/943,269 patent/US20250064828A1/en not_active Abandoned
- 2024-11-11 US US18/943,165 patent/US20250064826A1/en not_active Abandoned
-
2025
- 2025-03-21 US US19/087,084 patent/US20260007682A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025084921A5 (OSRAM) | ||
| JP2007500244A5 (OSRAM) | ||
| JP2015518006A (ja) | キシリトール系の抗粘膜組成物及び関連する方法並びに組成物 | |
| JP2016534142A5 (OSRAM) | ||
| CN102159244A (zh) | 包含减充血剂和皮质类固醇的鼻内组合物 | |
| JP2005504804A5 (OSRAM) | ||
| JP2008540532A5 (OSRAM) | ||
| JP2021513558A5 (OSRAM) | ||
| RU2361593C3 (ru) | Комбинация азеластина и стероидов | |
| JP2012520882A5 (OSRAM) | ||
| JP2017002035A5 (OSRAM) | ||
| JP2006528990A5 (OSRAM) | ||
| JP2012533554A5 (OSRAM) | ||
| JP2022511335A5 (OSRAM) | ||
| JP2024544393A5 (OSRAM) | ||
| JP2023531596A5 (OSRAM) | ||
| ZA202212128B (en) | Combination of alcaftadine and a corticosteroid | |
| JP2023520323A5 (OSRAM) | ||
| EP1847256B1 (en) | Antibacterial compositions for the treatment of infections of the upper and lower airways | |
| NO333334B1 (no) | Farmasoytisk preparat, samt slikt preparat for behandling av rhinitt | |
| JP2022552520A5 (OSRAM) | ||
| JP2022503733A5 (OSRAM) | ||
| JP2023531725A5 (OSRAM) | ||
| JP6931493B2 (ja) | 緑内障治療用点眼組成物 | |
| ES2197781A1 (es) | Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. |